Evidence map›Paper›PMID 39456935›Full record

ArticleInternational journal of molecular sciences2024

Assessing the Potential of 1,2,3-Triazole-Dihydropyrimidinone Hybrids Against Cholinesterases: In Silico, In Vitro, and In Vivo Studies.

Carlos M Gastalho, Ana M Sena, Óscar López, José G Fernández-Bolaños, Alfonso T García-Sosa, Florbela Pereira, Célia M Antunes, Ana R Costa, Anthony J Burke, Elisabete P Carreiro

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Carlos M GastalhoLAQV-REQUIMTE, Institute for Research and Advanced Training (IIFA), University of Évora, Rua Romão Ramalho, 59, 7000-671 Évora, Portugal.ORCID 0000-0002-4077-9755
Ana M SenaDepartment of Chemistry and Biochemistry, School of Sciences and Technologies, University of Évora, Rua Romão Ramalho, 59, 7000-671 Évora, Portugal.ORCID 0000-0001-5397-8684
Óscar LópezDepartamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, Apartado 1203, E-41071 Seville, Spain.
José G Fernández-BolañosDepartamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, Apartado 1203, E-41071 Seville, Spain.
Alfonso T García-SosaInstitute of Chemistry, University of Tartu, Ravila 14 A, 50411 Tartu, Estonia.ORCID 0000-0003-0542-4446
Florbela PereiraLAQV-REQUIMTE, Department of Chemistry, NOVA School of Science and Technology, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal.ORCID 0000-0003-4392-4644
Célia M AntunesInstitute of Earth Sciences, Institute of Research and Advanced Training, University of Évora, 7000-671 Évora, Portugal.ORCID 0000-0001-8906-1085
Ana R CostaInstitute of Earth Sciences, Institute of Research and Advanced Training, University of Évora, 7000-671 Évora, Portugal.ORCID 0000-0003-3854-9130
Anthony J BurkeLAQV-REQUIMTE, Institute for Research and Advanced Training (IIFA), University of Évora, Rua Romão Ramalho, 59, 7000-671 Évora, Portugal.
Elisabete P CarreiroLAQV-REQUIMTE, Institute for Research and Advanced Training (IIFA), University of Évora, Rua Romão Ramalho, 59, 7000-671 Évora, Portugal.ORCID 0000-0001-8117-7737

Funding

Estonian Research Council grant PRG1509Fundação para a Ciência e a tecnologia UIDB/00313/2020 | UIDP/00313/2020Fundação para a Ciência e a Tecnologia FCT/ MCTES; UIDB/50006/2020|UIDP/50006/2020MCIN/AEI/10.13039/501100011033 PID2020-116460RB-I00
6 · The paper itself

Abstract

Combining the pharmacological properties of the 1,2,3-triazole and dihydropyrimidinone classes of compounds, two small families of mono- and di(1,2,3-triazole)-dihydropyrimidinone hybrids, A and B, were previously synthesized. The main objective of this work was to investigate the potential anti-Alzheimer effects of these hybrids. The inhibitory activities of cholinesterases (AChE and BuChE), antioxidant activity, and the inhibitory mechanism through in silico (molecular docking) and in solution (STD-NMR) experiments were evaluated. The 1,2,3-triazole-dihydropyrimidinone hybrids (A and B) showed moderate in vitro inhibitory activity on eqBuChE (IC

Indexed as

ButyrylcholinesteraseCholinesterase InhibitorsMolecular Docking SimulationPyrimidinonesTriazolesAcetylcholinesteraseAnimalsAntioxidantsComputer SimulationHumansAcetylcholinesteraseAntioxidantsButyrylcholinesteraseCholinesterase InhibitorsPyrimidinonesTriazoles1,2,3-triazoleantioxidant activitycholinesterasesdihydropyrimidinonedockingSTD-NMR

Identifiers

PMID39456935
PMCPMC11508620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.